{"id":5903,"date":"2024-11-22T13:34:04","date_gmt":"2024-11-22T13:34:04","guid":{"rendered":"https:\/\/oncopeptides.com\/about\/valberedning-2025\/"},"modified":"2026-03-06T10:13:18","modified_gmt":"2026-03-06T10:13:18","slug":"valberedning-2025","status":"publish","type":"about-us","link":"https:\/\/oncopeptides.com\/sv\/om-oss\/corporate-governance\/kommitteer\/valberedning-2025\/","title":{"rendered":"Valberedning 2025"},"content":{"rendered":"<p class=\"preamble\">Enligt principerna f\u00f6r tills\u00e4ttande av valberedningen i Oncopeptides AB (publ) ska valberedningen inf\u00f6r \u00e5rsst\u00e4mman 2025 best\u00e5 av ledam\u00f6ter utsedda av de tre st\u00f6rsta aktie\u00e4garna i fr\u00e5ga om r\u00f6standel per utg\u00e5ngen av tredje kvartalet 2024 som \u00e4r villiga att delta i valberedningen, tillsammans med styrelsens ordf\u00f6rande.<\/p>\n<p>Valberedningen inf\u00f6r \u00e5rsst\u00e4mman 2025 best\u00e5r av f\u00f6ljande personer som tillsammans representerar cirka 23 procent av antalet aktier och r\u00f6ster i bolaget baserat p\u00e5 aktie\u00e4garinformationen per utg\u00e5ngen av september 2024.<\/p>\n<ul>\n<li>Staffan Lindstrand, utsedd av HealthCap VI L.P.<\/li>\n<li>Jonas Brambeck, utsedd av Jakob Lindberg<\/li>\n<li>Anna Henricsson, utsedd av Handelsbanken fonder<\/li>\n<li>Per Wold-Olsen, styrelsens ordf\u00f6rande<\/li>\n<\/ul>\n<p>Valberedningens f\u00f6rslag kommer att presenteras i kallelsen till \u00e5rsst\u00e4mman 2025 och under \u00c5rsst\u00e4mma 2025 h\u00e4r p\u00e5 webbplatsen.<\/p>\n<p>Aktie\u00e4gare som \u00f6nskar l\u00e4mna f\u00f6rslag till valberedningen kan g\u00f6ra det genom att skicka ett e-postmeddelande till <a href=\"mailto:info@oncopeptides.com\">info@oncopeptides.com<\/a> (\u00e4mnesrad \u201cValberedningen\u201d) eller genom brev till:<br \/>\nOncopeptides AB<br \/>\nAttn: Oncopeptides valberedning<br \/>\nLuntmakargatan 46<br \/>\nSE-111 37 Stockholm, Sverige<\/p>\n<p>Ett f\u00f6rslag m\u00e5ste n\u00e5 valberedningen senast den 3 april 2025 f\u00f6r att inkluderas i kallelsen och dagordningen f\u00f6r \u00e5rsst\u00e4mman.<\/p>\n","protected":false},"featured_media":0,"parent":5990,"template":"","meta":{"_acf_changed":false},"protected-content":[],"class_list":["post-5903","about-us","type-about-us","status-publish","hentry"],"acf":[],"_links":{"self":[{"href":"https:\/\/oncopeptides.com\/sv\/wp-json\/wp\/v2\/about-us\/5903","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/oncopeptides.com\/sv\/wp-json\/wp\/v2\/about-us"}],"about":[{"href":"https:\/\/oncopeptides.com\/sv\/wp-json\/wp\/v2\/types\/about-us"}],"version-history":[{"count":1,"href":"https:\/\/oncopeptides.com\/sv\/wp-json\/wp\/v2\/about-us\/5903\/revisions"}],"predecessor-version":[{"id":5991,"href":"https:\/\/oncopeptides.com\/sv\/wp-json\/wp\/v2\/about-us\/5903\/revisions\/5991"}],"up":[{"embeddable":true,"href":"https:\/\/oncopeptides.com\/sv\/wp-json\/wp\/v2\/about-us\/5990"}],"wp:attachment":[{"href":"https:\/\/oncopeptides.com\/sv\/wp-json\/wp\/v2\/media?parent=5903"}],"wp:term":[{"taxonomy":"protected-content","embeddable":true,"href":"https:\/\/oncopeptides.com\/sv\/wp-json\/wp\/v2\/protected-content?post=5903"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}